This inventor holds 5 USPTO granted patents and 2 EPO patents. Top assignee: Vanderbilt University. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2025
Title: The Innovative Contributions of Bin Zhao
Introduction
Bin Zhao is a prominent inventor based in Brentwood, TN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific proteins involved in cancer progression. With a total of 5 patents to his name, Zhao's work is paving the way for new treatment options.
Latest Patents
Zhao's latest patents focus on substituted indole Mcl-1 inhibitors. These inventions provide compounds that inhibit the activity of the anti-apoptotic Bcl-2 family member Myeloid cell leukemia-1 (Mcl-1) protein. The patents also detail pharmaceutical compositions and methods for using these compounds to treat diseases characterized by the over-expression or dysregulation of Mcl-1 protein, such as cancer.
Career Highlights
Zhao is affiliated with Vanderbilt University, where he conducts research and develops innovative solutions in the pharmaceutical field. His work has garnered attention for its potential impact on cancer treatment, showcasing his dedication to advancing medical science.
Collaborations
Zhao collaborates with fellow researcher Zhiguo Bian, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Bin Zhao's contributions to the field of pharmaceuticals through his patents and research at Vanderbilt University highlight his role as a key innovator in cancer treatment. His work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile